Prognostic genome and transcriptome signatures in colorectal cancers.

Autor: Nunes L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Li F; HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS), BGI Research, Hangzhou, China.; Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI Research, Shenzhen, China.; Institute of Intelligent Medical Research (IIMR), BGI Genomics, Shenzhen, China., Wu M; HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS), BGI Research, Hangzhou, China.; Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI Research, Shenzhen, China.; Institute of Intelligent Medical Research (IIMR), BGI Genomics, Shenzhen, China., Luo T; HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS), BGI Research, Hangzhou, China.; Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI Research, Shenzhen, China.; Institute of Intelligent Medical Research (IIMR), BGI Genomics, Shenzhen, China., Hammarström K; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Torell E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ljuslinder I; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Mezheyeuski A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Edqvist PH; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Löfgren-Burström A; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden., Zingmark C; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden., Edin S; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden., Larsson C; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Mathot L; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Osterman E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Osterlund E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Neves I; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Yacoub N; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Guðnadóttir U; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Birgisson H; Department of Surgical Sciences, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden., Enblad M; Department of Surgical Sciences, Uppsala University, Akademiska sjukhuset, Uppsala, Sweden., Ponten F; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Palmqvist R; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden., Xu X; HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS), BGI Research, Hangzhou, China., Uhlén M; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.; Science for Life Laboratory, Department of Protein Science, KTH-Royal Institute of Technology, Stockholm, Sweden., Wu K; HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS), BGI Research, Hangzhou, China. wukui@genomics.cn.; Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI Research, Shenzhen, China. wukui@genomics.cn.; Institute of Intelligent Medical Research (IIMR), BGI Genomics, Shenzhen, China. wukui@genomics.cn., Glimelius B; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. bengt.glimelius@igp.uu.se., Lin C; HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences (CAS), BGI Research, Hangzhou, China. lincong@genomics.cn.; Guangdong Provincial Key Laboratory of Human Disease Genomics, Shenzhen Key Laboratory of Genomics, BGI Research, Shenzhen, China. lincong@genomics.cn.; Institute of Intelligent Medical Research (IIMR), BGI Genomics, Shenzhen, China. lincong@genomics.cn., Sjöblom T; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. tobias.sjoblom@igp.uu.se.

Publikováno v: Nature [Nature] 2024 Sep; Vol. 633 (8028), pp. 137-146. Date of Electronic Publication: 2024 Aug 07.

Omental metastases in patients with pseudomyxoma peritonei or colorectal peritoneal metastases - is routine omentectomy justified?

Autor: Enblad M; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden., Birgisson H; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden., Ghanipour L; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden., Cashin P; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden., Graf W; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden.

Publikováno v: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2024; Vol. 41 (1), pp. 2372356. Date of Electronic Publication: 2024 Jun 27.

Next generation pan-cancer blood proteome profiling using proximity extension assay.

Autor: Álvez MB; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Edfors F; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., von Feilitzen K; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Zwahlen M; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Mardinoglu A; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, SE1 9RT, UK., Edqvist PH; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Sjöblom T; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Lundin E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Rameika N; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Enblad G; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Lindman H; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Höglund M; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Hesselager G; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Stålberg K; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden., Enblad M; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Simonson OE; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Häggman M; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Axelsson T; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Åberg M; Department of Medical Sciences, Clinical Chemistry and SciLifeLab Affinity Proteomics, Uppsala University, Uppsala, Sweden., Nordlund J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Zhong W; Science for Life Laboratory, Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden., Karlsson M; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Gyllensten U; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Ponten F; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Fagerberg L; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Uhlén M; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden. mathias.uhlen@scilifelab.se.; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. mathias.uhlen@scilifelab.se.

Publikováno v: Nature communications [Nat Commun] 2023 Jul 18; Vol. 14 (1), pp. 4308. Date of Electronic Publication: 2023 Jul 18.

Mucinous rectal cancers: clinical features and prognosis in a population-based cohort.

Autor: Enblad M; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden., Hammarström K; Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden., Folkesson J; Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden., Imam I; Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden., Golubovik M; Department of Radiology, Uppsala University Hospital, Uppsala, Sweden., Glimelius B; Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology, Uppsala University, Uppsala, Sweden.

Publikováno v: BJS open [BJS Open] 2022 Mar 08; Vol. 6 (2).

Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Autor: Birgisson H; Department of Surgical Sciences, Uppsala University, Sweden. Electronic address: helgi.birgisson@surgsci.uu.se., Enblad M; Department of Surgical Sciences, Uppsala University, Sweden., Artursson S; Department of Surgical Sciences, Uppsala University, Sweden., Ghanipour L; Department of Surgical Sciences, Uppsala University, Sweden., Cashin P; Department of Surgical Sciences, Uppsala University, Sweden., Graf W; Department of Surgical Sciences, Uppsala University, Sweden.

Publikováno v: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Dec; Vol. 46 (12), pp. 2283-2291. Date of Electronic Publication: 2020 Aug 05.